[Alpha 1-adrenoceptor antagonists for treatment of prostatic hyperplsia].
Yokota
Takashi
T
Department of Urology, School of Medicine, Fukushima Medical University.
Shishido
Keiichi
K
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000726:Androgen Antagonists / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D011224:Prazosin / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D018340:Receptors, Adrenergic, alpha-1 / Q000502:physiology; D013449:Sulfonamides / Q000627:therapeutic use; D000077409:Tamsulosin
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists; D018340:Receptors, Adrenergic, alpha-1; D013449:Sulfonamides; D000077409:Tamsulosin; D011224:Prazosin